Identification |
Name: | 1-Butanone,3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)- |
Synonyms: | 1,2,4-Triazolo[4,3-a]pyrazine,7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-(9CI);7-[1-Oxo-3-amino-4-(2,4,5-trifluorophenyl)butyl]-3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine |
CAS: | 823817-56-7 |
Molecular Formula: | C16H15 F6 N5 O |
Molecular Weight: | 0 |
InChI: | InChI=1/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2 |
Molecular Structure: |
|
Properties |
Flash Point: | 274.3°C |
Boiling Point: | 529.9°C at 760 mmHg |
Density: | 1.61g/cm3 |
Refractive index: | 1.59 |
Flash Point: | 274.3°C |
Storage Temperature: | Refrigerator |
Usage: | A trizolopyrazine dipeptidyl peptidase IV inhibitor. It has recently been approved for the therapy of type II diabetes. |
Safety Data |
|
|